{"spec": {"completion_fns": ["open-assistant:OpenAssistant/oasst-rlhf-3-llama-30b-5k-steps"], "eval_name": "mmlu-virology.val.ab-v1", "base_eval": "mmlu-virology", "split": "val", "run_config": {"completion_fns": ["open-assistant:OpenAssistant/oasst-rlhf-3-llama-30b-5k-steps"], "eval_spec": {"cls": "evals.elsuite.multiple_choice:MultipleChoice", "args": {"dataset": "hf://cais/mmlu?name=virology&split=validation"}, "key": "mmlu-virology.val.ab-v1", "group": "mmlu"}, "seed": 20220722, "max_samples": null, "command": "./evaluate.py -e -m open-assistant:OpenAssistant/oasst-rlhf-3-llama-30b-5k-steps -b openai-evals vicuna human-eval-plus", "initial_settings": {"visible": true}}, "created_by": "", "run_id": "230618220428OPBM5EKQ", "created_at": "2023-06-18 22:04:28.971311"}}
{"final_report": {"accuracy": 0.2777777777777778}}
{"run_id": "230618220428OPBM5EKQ", "event_id": 0, "sample_id": "mmlu-virology.val.3", "type": "match", "data": {"correct": false, "expected": "B", "picked": null, "sampled": "The correct answer is B) All of the above. The \"test and treat\" strategy in HIV prevention relies on the availability of resources for HIV testing and treatment, the willingness of infected individuals to be tested and to begin treatment, and the proportion of infected individuals who are willing to be tested.[1] The \"test and treat\" approach seeks to reduce the spread of HIV in a population by providing antiretroviral therapy to all individuals who are HIV positive, regardless of the stage of the disease or their individual circumstances.[2] The strategy is meant to reduce the amount of time that people infected with HIV are able to transmit the virus to others by reducing the amount of virus in their bodies and thus reducing their infectiousness.[3] While \"test and treat\" has shown promise in reducing the spread of HIV, there are still concerns about its implementation and effectiveness, particularly in areas where resources are limited or access to care is difficult.[4] However, the strategy is being explored as a potential means of curbing the global HIV epidemic, particularly in combination with other prevention strategies like condom distribution and needle exchange programs.[5] \n\nSome evidence suggests that \"test and treat\" can be effective at reducing the spread of HIV through the population, particularly if implemented as part of a comprehensive package of prevention services. For example, a study in the journal PLOS Medicine found that \"test and treat\" reduced the spread of HIV within heterosexual populations of Kenya and Uganda by 20-30 percent compared to standard prevention strategies like condom distribution and behavioral counseling.[1] Some evidence also suggests that \"test and treat\" may be particularly effective at reducing the spread of HIV among high-risk populations, such as men who have sex with men and people who inject dru", "prompt": "\nPlease answer with the letter of the correct answer.\n\n“Test and treat” depends on:\nA) The availability of resources for persons testing HIV positive\nB) All of the above\nC) The proportion of infected persons willing to be tested\nD) The willingness of persons testing HIV positive to begin treatment", "options": ["B"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.296520+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 1, "sample_id": "mmlu-virology.val.16", "type": "match", "data": {"correct": false, "expected": "D", "picked": null, "sampled": "A.\nB.\nD.\nA.\nThe correct order in which the virus lifecycle should appear in your text would be:\n1) Virus absorption\n2) Virus penetration\n3) Exit of viruses from the cell\n4) Virus RNA and DNA replication. Blocking the exit of viruses from the cell is least likely to be blocked by antivirals, as the goal of antivirals is to interfere with the virus' ability to replicate and infect new cells.\n\nHowever, as before, please make sure to consult up-to-date research in order to guarantee the accuracy of your claims.\nPlease feel free to write back if you have further questions or need additional support. Please mention your name in the beginning of your message.\n\nBest regards,\n[Your Name]\n[Open Assistant]\n[AI-driven personalised newsletters]", "prompt": "\nPlease answer with the letter of the correct answer.\n\nWhich point in the replication cycle appears most easily blocked by antivirals?\nA) Virus absorption\nB) Virus penetration\nC) Exit of viruses from the cell\nD) Virus RNA and DNA replication", "options": ["D"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.296977+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 2, "sample_id": "mmlu-virology.val.5", "type": "match", "data": {"correct": false, "expected": "A", "picked": null, "sampled": "In this problem, we need to determine the annual incidence of hepatitis C infection in IV drug users in town A.\n\nWe are given the following information:\n\n* A survey of 10,000 IV drug users in town A found that 1,000 were infected with hepatitis.\n* During follow-up, 100 patients with hepatitis C infection died, and 100 IV drug users acquired hepatitis C.\n\nTo determine the annual incidence of hepatitis C infection, we first need to determine the number of new infections that have occurred. We can do this by subtracting the number of patients who died from the number of new infections:\n\nNumber of new infections = 100 - 100 = 0\n\nSince the number of new infections is 0, the annual incidence of hepatitis C infection is 0/10,000.\n\nTherefore, the answer is:\n\nD) 100/9,000 (The answer is obtained using the formula: Number of new infections/Total population at risk. In this case, the number of new infections is 100 and the total population at risk is 10,000.)", "prompt": "\nPlease answer with the letter of the correct answer.\n\nIn a survey of 10,000 IV drug users in town A, 1,000 turn out to be infected with hepatitis follow-up, 100 patients with hepatitis C infection die. Also during follow-up, 100 IV drug users acquire hepatitis C. Which of the following is the best estimate of the annual incidence of hepatitis C infection in IV drug users in town A?\nA) 1,100/10,000\nB) 100/10,000\nC) 1,000/10,000\nD) 100/9,000", "options": ["A"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.297425+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 3, "sample_id": "mmlu-virology.val.10", "type": "match", "data": {"correct": false, "expected": "C", "picked": null, "sampled": "The correct answer is D) All viruses have the same basic geometry.\n\nThere are several types of viruses, including both DNA and RNA viruses, which can have a range of different geometric structures. The structure of a virus is determined by the shape of its proteins and the arrangement of its genetic material. Some viruses, such as the influenza virus, have a bullet shape, while others, such as the common cold virus, are more spherical. Some viruses, such as the norovirus, have a shell-like structure made up of multiple layers of proteins.\n\nAs for the options, they are:\n\nA) The nucleic acid is commonly linear. Some viruses do have linear DNA or RNA, but this is not accurate for all viruses. Furthermore, the presence of non-linear nucleic acid does not determine the shape of the virus.\nB) All viruses have a lipid bilayer. Viruses can have a variety of shell-like structure, but not necessarily a lipid bilayer. Some viruses have a protein capsid with lipid tails, but the lipids are not arranged in a bilayer structure.\nC) Virus nucleocapsids are either icosahedral or helical. The icosahedral shape is indeed formed by 20 identical equilateral triangles. However, viruses can also have helical (such as tobacco mosaic virus), cubic (such as herpes), or other shapes. While many viruses appear to have icosahedral or helical structure, it is not to the exclusion of all other possibilities.\nD) All viruses have the same basic geometry. As mentioned, while there are many common geometric features among different viruses, they tend to have more diverse geometric shape than D) suggests, which seems to prescribe a single common structure", "prompt": "\nPlease answer with the letter of the correct answer.\n\nViruses of different families have varied geometric structures. Which of the following is true?\nA) The nucleic acid is commonly linear\nB) All viruses have a lipid bilayer\nC) Virus nucleocapsids are either icosahedral or helical\nD) All viruses have the same basic geometry", "options": ["C"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.297812+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 4, "sample_id": "mmlu-virology.val.11", "type": "match", "data": {"correct": false, "expected": "B", "picked": null, "sampled": "C) Zero, which means 0 people have antibodies to the polyomavirus family. While it is impossible for the percentage to be 0 as the question is asking for a percentage in the population, the answer to the quiz was intended to be an impossible question.\n\nThere is no polyomavirus that people should have antibodies or vaccines to, only animals, and the only human disease associated with polyomaviruses in the literature is associated with immunosuppression after organ transplantation. While some strains of SV40 viruses that are polyomaviruses have been found in some human cancers, this still doesn't mean humans have any antibody responses to it, as the most commonly used polyomavirus vaccines only contain the VP1 proteins which are not associated with cancer risk and only provide cross protection to unknown new viruses that might emerge. The CDC states that polyomavirus is rare causes cancer in people and usually only in conjunction with organ transplantation.\n\nPlease let me know if you need anything else.", "prompt": "\nPlease answer with the letter of the correct answer.\n\nWhat percentage of the population have antibodies to the polyomavirus family\nA) 0.00%\nB) 90%\nC) Zero\nD) 1%", "options": ["B"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.298268+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 5, "sample_id": "mmlu-virology.val.4", "type": "match", "data": {"correct": false, "expected": "D", "picked": null, "sampled": "Cytotoxic T cells can be activated by identifying virus peptides presented by MHC-I.\"\n\nThe correct answer is D.\n\nI hope that helps! Do you have any other questions I can help you with?", "prompt": "\nPlease answer with the letter of the correct answer.\n\nCytotoxic T cells can be activated via which of the following?\nA) By releasing complement\nB) By reacting with budding viruses\nC) By identifying virus peptides presented by antibodies\nD) By identifying virus peptides presented by MHC-I", "options": ["D"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.298564+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 6, "sample_id": "mmlu-virology.val.13", "type": "match", "data": {"correct": true, "expected": "B", "picked": "B", "sampled": "B) Mechanism of replication of DNA.", "prompt": "\nPlease answer with the letter of the correct answer.\n\nWhich of the following was a major discovery of molecular biology when the adenovirus replication strategy was uncovered?\nA) The function of RT\nB) Mechanism of replication of DNA\nC) The importance and frequency of mRNA splicing\nD) The speed of action of viral DNA dependent DNA polymerase", "options": ["B"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.299115+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 7, "sample_id": "mmlu-virology.val.17", "type": "match", "data": {"correct": false, "expected": "D", "picked": null, "sampled": "A) Passage of live virus from cell to cell and a search for less virulent mutants.\n\nVirus attenuation is the process of weakening the virulence of a virus in order to make it safe for use as a vaccine. One way to attenuate a virus is to pass it through a series of cell cultures and selectively isolate less virulent mutants that emerge during the process. This method is known as \"serial passage\" of the virus.\n\nSerial passage involves repeatedly infecting host cells with the virus, allowing the virus to replicate and mutate, and then isolating and propagating the least virulent mutants. This process can be done in a laboratory, and it is how some viruses are attenuated for use as vaccines.\n\nWhile there are other methods for attenuating viruses, such as using low temperatures, recovering naturally less virulent strains, and random mutagenesis, serial passage is a common method for creating vaccines that are effective, yet have reduced ability to cause disease.\n\nTherefore, the correct answer is A), as virus attenuation involves passage of live virus from cell to cell and a search for less virulent mutants.", "prompt": "\nPlease answer with the letter of the correct answer.\n\nWhat is virus attenuation in practical terms for successful vaccine discovery?\nA) Passage of live virus from cell to cell and a search for less virulent mutants\nB) As (a) but using low temperature (33oC) to select cold adapted mutants\nC) Recovery of a naturally occurring 'wild' virus which is naturally less virulent\nD) Direct random mutagenesis to create a less virulent mutant", "options": ["D"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.299856+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 8, "sample_id": "mmlu-virology.val.1", "type": "match", "data": {"correct": false, "expected": "D", "picked": null, "sampled": "The odds ratio that a patient diagnosed with pancreatic cancer is a current smoker compared to a patient without pancreatic cancer can be calculated as:\n\n(50/40) / (60/80)\n\nor\n\n(50/40)/((50+40)/(60+80))\n\nwhich is the same as\n\n(50/40)/(40/50+60/120) = 4/4.41 or approximately 0.90.\n\nSo, the answer is D.", "prompt": "\nPlease answer with the letter of the correct answer.\n\nAt a specific hospital, patients diagnosed with pancreatic carcinoma are asked about their current smoking status. At the same hospital, patients without pancreatic carcinoma are also asked about their current smoking status. The following table is constructed.  Smokers Non-smokers Total  Pancreatic Cancer 50 40 90  No Pancreatic Cancer 60 80 140  Total 110 120 230  What is the odds ratio that a patient diagnosed with pancreatic cancer is a current smoker compared to a patient without pancreatic cancer?\nA) (50/40)/(60/80)\nB) (50/110)/(40/120)\nC) (50/60)/(40/80)\nD) (50/90)/(60/140)", "options": ["D"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.300137+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 9, "sample_id": "mmlu-virology.val.7", "type": "match", "data": {"correct": false, "expected": "A", "picked": null, "sampled": "B) a. and c. above. The primary goal of public health is to protect the uninfected and protect the identity of those who have died from an infectious disease.", "prompt": "\nPlease answer with the letter of the correct answer.\n\nThe primary goal of public health is to:\nA) Protect the uninfected\nB) a. and c. above\nC) Protect the infected\nD) Protect the identity of those who have died from an infectious disease", "options": ["A"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.300575+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 10, "sample_id": "mmlu-virology.val.15", "type": "match", "data": {"correct": false, "expected": "B", "picked": null, "sampled": "A) Blood\n\nThe diagnosis of hepatitis B is typically made by detecting the presence of the hepatitis B virus (HBV) in the blood. This can be done through a blood test that looks for HBV antibodies or for the presence of HBV DNA.\n\nBlood tests may include the following:\n\n1. HBsAg (hepatitis B surface antigen): This antigen is produced by the virus and can be detected in the blood for several months or even years.\n2. Anti-HBs (hepatitis B surface antibody): This antibody is produced by the immune system to fight against the virus. It is usually present in people who have recovered from a previous HBV infection or have been vaccinated against HBV.\n3. HBcAb (hepatitis B core antibody): This antibody is produced by the immune system in response to the HBV core antigen. It is typically present in people who have been infected with HBV for a long time.\n4. HBeAg (hepatitis B e antigen): This antigen is produced by the virus and is an indicator of active viral replication. It is present in the blood of people who have acute or chronic HBV infection.\n\nOther clinical samples, such as liver biopsy, faeces samples, or throat swabs, are not commonly used to diagnose hepatitis B. However, these samples may be used in certain situations, such as when a blood test is negative but the doctor suspects an HBV infection.", "prompt": "\nPlease answer with the letter of the correct answer.\n\nWhich clinical sample is used to diagnose hepatitis B?\nA) Blood\nB) Liver biopsy\nC) Faeces samples\nD) Throat swab", "options": ["B"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.301929+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 11, "sample_id": "mmlu-virology.val.12", "type": "match", "data": {"correct": true, "expected": "D", "picked": "D", "sampled": "D) All of the above.\n\nThe study published in the Journal of Acquired Immunodeficiency Syndromes (JAIDS) found that among men who have sex with men (MSM) in Shanghai, China, those with HIV infection were almost five times more likely to be infected with early syphilis when compared to those without HIV infection. Moreover, the men who had HIV infection and sex with recent internet partners were more than seven times more likely to have early syphilis when compared to those without HIV infection but who engaged in both behaviors.\n\nTherefore, all of the above statements are correct, as all three factors (HIV infection, sex with internet partners, and early syphilis) were found to be associated with each other in the study population.", "prompt": "\nPlease answer with the letter of the correct answer.\n\nIn MSM, early syphilis was found to be associated with:\nA) Use of methamphetamine\nB) Sex with recent internet partners\nC) HIV infection\nD) All of the above", "options": ["D"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.302405+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 12, "sample_id": "mmlu-virology.val.2", "type": "match", "data": {"correct": false, "expected": "C", "picked": null, "sampled": "All except C (The first viruses came from outer space) are true.\n\nThere is strong evidence of viruses being around at least 3.5 billion years ago.\n\nRecent discoveries have shown that there are viruses in rocks deep under the ocean at a depth of 11,000 meters away from other life forms which points to them being around at least 700 million years ago.\nAll of these were before the first known life forms!\nAll the above facts point to the existence of viruses being even before the existence of cells and their being a primordial organism (before even bacteria).\nThey have co-evolved along the path of evolution all along just like everything else and they are still evolving.\nThe only thing they need is DNA or RNA to replicate and the simplest genome known today is one belonging to this tiny virus.\n\nAlmost all viruses that we know of today need to infect host cells in order to replicate which means they have to evolve along with their hosts as well and evolve themselves to counter the defenses of these cells.\nIt is known that HIV which is a virus that attacks the immune system itself and it uses some key proteins to get across the cell wall that separates it from its host. But since this also requires it to make proteins from those genes on its DNA it also evolves along with its host so that its not recognized and that is how it sustains itself.\nHIV is unique in the sense that it does not go out of the cell to make new copies of itself.\nUsually viruses will bring their DNA along with it and insert it into the host cell chromosomes or even incorporate some chromosomes into themselves and make even more copies and the virus uses all of them in a way that is almost like a program encoded in a", "prompt": "\nPlease answer with the letter of the correct answer.\n\nSome facts about viruses: identify the incorrect fact:\nA) They can infect all forms of life even themselves!\nB) Viruses evolved before bacteria which in turn evolved before cells\nC) The first viruses came from outer space\nD) The first viruses arose 2 billion years ago as parasites of Algae", "options": ["C"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.302852+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 13, "sample_id": "mmlu-virology.val.0", "type": "match", "data": {"correct": false, "expected": "C", "picked": null, "sampled": "A) Immuno test B) Clinical history of recent travel and living in endemic area C) RT PCR kit\n\nThe correct answer is:\nA) Immuno test B) Clinical history of recent travel and living in endemic area C) RT PCR kit\n\nThe correct answer is A), B), and C). The diagnosis of arenavirus infection typically involves a combination of tests, including immunoglobulin M (IgM) antibody tests, PCR (polymerase chain reaction), and serology. Clinical history, including recent travel to or living in an endemic area, can also be important in making a diagnosis. While cell culture may be used in the diagnosis of some viral infections, it is not routinely used for arenavirus infection.\n\nA) Immuno test is correct, because Immuno test is one of the primary methods to diagnose arenavirus infection\nB) Clinical history of recent travel and living in endemic area is correct, because clinical history is important in diagnosis of arenavirus infection\nC) RT PCR kit is correct, because PCR is one of the primary test to diagnose arenavirus infection.\n\nSo the answer for the question is A), B), and C).\n\nPlease feel free to continue with your original question", "prompt": "\nPlease answer with the letter of the correct answer.\n\nWhat is essential for diagnosis of arenavirus infection?\nA) Immuno test\nB) Clinical history of recent travel and living in endemic area\nC) RT PCR kit\nD) Cell culture laboratory (laboratory IV)", "options": ["C"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.303488+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 14, "sample_id": "mmlu-virology.val.9", "type": "match", "data": {"correct": true, "expected": "C", "picked": "C", "sampled": "Cohort study - as the investigator wants to investigate the effect of a certain outcome (neural tube defects after acetaminophen use during pregnancy) in a defined group of people (exposed to acetaminophen during pregnancy vs. not exposed). The study would look at the incidence of the outcome in both groups over time. This would allow her to examine the relationship between the exposure (acetaminophen use) and outcome (neural tube defects). It is more susceptible to confounding than randomized controlled trial but more valid than case-control study. However, since pregnancy lasts for a long duration, cohort study can be susceptible to recall bias. In this case-control study might be preferred when the investigator wants to look for the associations between the exposure and outcomes which is retrospectively assessed.", "prompt": "\nPlease answer with the letter of the correct answer.\n\nAn investigator suspects that acetaminophen use during the first trimester of pregnancy can cause neural tube defects. She estimates the risk of neural tube defect in the general population is 1:1,000. Which of the following is the best study design to investigate the hypothesis?\nA) Case-control study\nB) Clinical trial\nC) Ecologic Study\nD) Cohort study", "options": ["C"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.303871+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 15, "sample_id": "mmlu-virology.val.8", "type": "match", "data": {"correct": true, "expected": "C", "picked": "C", "sampled": "C) Compact icosahedron structure. The herpes virus has a compact icosahedron structure with a characteristic hexagonal arrangement of glycoproteins on its surface. Despite being small, the herpes virus has a complex structure and is made up of three main parts: the glycoprotein, the capsid, and the nucleocapsid. The capsid encloses the genetic material of the virus and protects it from being attacked by the immune system. The tegument is a layer of proteins covering the capsid.", "prompt": "\nPlease answer with the letter of the correct answer.\n\nWhat is the morphology of the herpes virion?\nA) Small round virus\nB) Baggy virion with over 50 types of spikes\nC) Compact icosahedron structure\nD) Complex with a membrane and tegument and icosahedron core", "options": ["C"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.304879+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 16, "sample_id": "mmlu-virology.val.6", "type": "match", "data": {"correct": true, "expected": "C", "picked": "C", "sampled": "C) ssRNA viruses with capped and polyadenylated RNA.", "prompt": "\nPlease answer with the letter of the correct answer.\n\nGenetically the flaviviruses are positive stranded and have which of the following properties?\nA) Viruses with a segmented RNA genome\nB) Circular RNA genome\nC) ssRNA viruses with capped and polyadenylated RNA\nD) Icosahedral viruses with no membrane", "options": ["C"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.305275+00:00"}
{"run_id": "230618220428OPBM5EKQ", "event_id": 17, "sample_id": "mmlu-virology.val.14", "type": "match", "data": {"correct": false, "expected": "D", "picked": null, "sampled": "B) (40/70)/(20/60)\n\nThe relative risk (RR) can be calculated as:\n\nRR = (p1 * p2) / (n1 * n2)\n\nwhere p1 and p2 are the proportions of disease in the exposed and unexposed groups, respectively, while n1 and n2 are the numbers of individuals in the exposed and unexposed groups.\n\nIn this case, the exposed group\n{A} (i.e., patients with a high baseline plasma fibrinogen level) has 40 patients that develop acute coronary syndrome out of 70 (40/70) and 30 patients that do not.\nThe unexposed group {B} (i.e., patients with a normal baseline plasma fibrinogen level) has 20 patients that develop acute coronary syndrome (20/60) and 40 patients that do not, so\nRR=(p1 * p2) / (n1 * n2) = [(40/70)*(20/60)]/(40*30) = (40/70)/(20/60)\n\nSo the best estimate of RR of acute coronary syndrome in expose group is (40/70)/(20/60) that corresponds to answer B.", "prompt": "\nPlease answer with the letter of the correct answer.\n\nAn observational study in diabetics assesses the role of an increased plasma fibrinogen level on the risk of cardiac events. 130 diabetic patients are followed for 5 years to assess the development of acute coronary syndrome. In the group of 60 patients with a normal baseline plasma fibrinogen level, 20 develop acute coronary syndrome and 40 do not. In the group of 70 patients with a high baseline plasma fibrinogen level, 40 develop acute coronary syndrome and 30 do not. Which of the following is the best estimate of relative risk in patients with a high baseline plasma fibrinogen level compared to patients with a normal baseline plasma fibrinogen level?\nA) (40*40)/(20*30)\nB) (40/70)/(20/60)\nC) (40/30)/(20/40)\nD) (40*70)/(20*60)", "options": ["D"]}, "created_by": "", "created_at": "2023-06-18 22:08:53.305920+00:00"}
